The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

archemedx.com

Founded Year

2012

Stage

Unattributed | Alive

Total Raised

$3.72M

Last Raised

$1.18M | 4 yrs ago

Revenue

$0000 

About ArcheMedX

ArcheMedX is a healthcare informatics and e-learning technology company. The company's mission is to build the structure required to transform medical education through new connected learning and assessment models.

ArcheMedX Headquarter Location

300 E Main St, Suite 101

Charlottesville, Virginia, 22902,

United States

+1-434-260-1850

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ArcheMedX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ArcheMedX is included in 1 Expert Collection, including Education Technology (Edtech).

E

Education Technology (Edtech)

2,512 items

Latest ArcheMedX News

ArcheMedX Bolsters Team, Appoints Kelly Ritch as Vice President...

Nov 14, 2019

Share Article Kelly Ritch's addition better equips ArcheMedX to scale the capabilities it provides to transform clinical operations. Kelly Ritch will apply 20 years of clinical operations experience to accelerate growth of the company’s clinical research business. CHARLOTTESVILLE, Va. (PRWEB)November 14, 2019 ArcheMedX , the company improving clinical trial readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform , with sponsors and CROs, ArcheMedX has appointed Kelly Ritch as Vice President of Clinical Research Solutions. Kelly will apply her 20 years of clinical operations experience to accelerate growth of the company’s clinical research business. “As the complexity and cost of clinical research increases, a key to reducing the risk of under-performing trials is ensuring the preparedness of staff and sites” said Ms. Ritch. She added, “I’m excited to join the ArcheMedX team and help clinical operations leaders make faster, more informed decisions that improve trial efficiency and outcomes.” Kelly is a dynamic and innovative executive adept at driving high-performance and long-term value through the applied use of software, data, and technology driven solutions for clinical research. Her operational expertise and strategic mindset will enable ArcheMedX to scale the capabilities it provides to a growing customer base. Nearly every clinical trial encounters operational challenges and according to industry reports 86% of trials experience a study startup delay and 72% of studies run more than one month behind schedule. These delays can have significant financial costs for each day that a trial impedes a product’s development and launch. At ArcheMedX, we arm trial stakeholders with more than an advanced training solution -- we provide the early warning detection they need to mitigate operational risk and reduce costly delays,” said ArcheMedX CEO and co-founder Joel Selzer. “This is a pivotal time for the clinical research sector, and we are thrilled to have an industry leader with Kelly’s breadth of experience join the team. With Kelly’s appointment we are better equipped to expand the product and commercial strategies at ArcheMedX that will transform clinical operations.” Kelly has previously led clinical data management, sales and marketing, clinical trial operations, and strategic partnerships with both sponsors and CROs. While creating and leading high-performance teams across clinical research functions, Kelly has had the opportunity to evaluate, implement, and develop a number of key software platforms used to support and improve clinical trial performance. Kelly has earned degrees from University of Virginia, University of North Carolina Chapel Hill, and University of Virginia Darden School of Business. -- About ArcheMedX ArcheMedX applies behavioral science to transform learning and generate actionable insights across the life sciences and healthcare industries. Ready, the company’s clinical trial readiness platform, enables clinical research leaders to evaluate and improve the preparedness of project teams and site personnel and serves as an early warning detection system to reduce the risks and costs associated with under-performing clinical trials. To learn more about our operational intelligence and workforce readiness solutions visit http://www.archemedx.com or follow ArcheMedX on LinkedIn . Share article on social media or email: View article via:

ArcheMedX Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ArcheMedX Rank

  • When was ArcheMedX founded?

    ArcheMedX was founded in 2012.

  • Where is ArcheMedX's headquarters?

    ArcheMedX's headquarters is located at 300 E Main St, Suite 101, Charlottesville.

  • What is ArcheMedX's latest funding round?

    ArcheMedX's latest funding round is Unattributed.

  • How much did ArcheMedX raise?

    ArcheMedX raised a total of $3.72M.

  • Who are the investors of ArcheMedX?

    Investors of ArcheMedX include Greyson Williams, Jaffray Woodriff and Virginia Venture Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.